Sanofi Pasteur has tapped Berg to learn more about biomarkers behind flu vaccine responses.

China's FDA approved a domestically developed Ebola vaccine based on a different virus type from GSK's and Merck's shots.

Young biotech Codagenix just secured $3 million in funding to advance its live-attenuated RSV vaccine candidate.

Affluent regions with more new moms are most likely to be spawning grounds for antivaccine tweets, a five-year study found.

A large-scale phase 3 study shows that Merck's Gardasil 9 vaccine protects against HPV-related cancers for at least six years.

In a temporary break from its corporate drama, Sinovac posted positive topline data from a phase 3 study of its chickenpox vaccine.

After a major cancer vaccine misstep, Bavarian Nordic reported positive six-week data from an ongoing phase 2 study on its RSV vaccine candidate.

Inovio and GeneOne have started a clinical study of their MERS vaccine in South Korea, where the virus took 36 lives in a 2015 outbreak.